Matches in Wikidata for { <http://www.wikidata.org/entity/Q91064317> ?p ?o ?g. }
- Q91064317 description "article scientifique publié en 2019" @default.
- Q91064317 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91064317 description "scientific article published on 02 November 2019" @default.
- Q91064317 description "wetenschappelijk artikel" @default.
- Q91064317 description "наукова стаття, опублікована 2 листопада 2019" @default.
- Q91064317 name "Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab" @default.
- Q91064317 name "Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab" @default.
- Q91064317 type Item @default.
- Q91064317 label "Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab" @default.
- Q91064317 label "Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab" @default.
- Q91064317 prefLabel "Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab" @default.
- Q91064317 prefLabel "Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab" @default.
- Q91064317 P1433 Q91064317-BC551D6A-C20D-4342-A33E-0257E8FB5489 @default.
- Q91064317 P1476 Q91064317-598348DA-3DAC-4B95-837E-6D25F01B88D5 @default.
- Q91064317 P2093 Q91064317-29C86AE9-588A-4189-8B09-FCA112CB1823 @default.
- Q91064317 P2093 Q91064317-412BF0F4-AE40-4E8D-B8B4-4791444A39B1 @default.
- Q91064317 P2093 Q91064317-6217E888-46EE-4CC3-8C1B-1BBBE8B8A2C1 @default.
- Q91064317 P2093 Q91064317-86256478-DF85-452D-905C-C4A5002FC436 @default.
- Q91064317 P2093 Q91064317-91E9A393-B03A-4052-8635-4ABF0BD82F5D @default.
- Q91064317 P2093 Q91064317-9202AF9E-5755-4F28-B3FB-2F64652060A4 @default.
- Q91064317 P2093 Q91064317-976BA295-A1EB-41AD-AE14-75CF2C094481 @default.
- Q91064317 P2093 Q91064317-A31530E6-6A1E-4C1B-BB24-4ED12FBD9B00 @default.
- Q91064317 P2093 Q91064317-AB134B51-979B-4D88-A90F-72ABACEA0880 @default.
- Q91064317 P2093 Q91064317-C28BF2F9-A18E-46FC-ACE3-3ABC43B960EA @default.
- Q91064317 P2093 Q91064317-CD52F55B-4488-4A84-BA7F-1CE2680EFC0A @default.
- Q91064317 P2093 Q91064317-D0661F7B-FA8D-4598-886F-B7D4D0A2E0CB @default.
- Q91064317 P2093 Q91064317-D2DB3A27-3591-4289-A0FD-BC310AD99331 @default.
- Q91064317 P2093 Q91064317-E9EF4FDF-D1D1-4C62-AA72-A3427931A10C @default.
- Q91064317 P2093 Q91064317-EEF50948-F1D9-4BB1-8F30-A342C89DCBB0 @default.
- Q91064317 P2093 Q91064317-FF4E082D-B1C2-4821-8C78-FE093677B173 @default.
- Q91064317 P2860 Q91064317-00B66D4E-38F9-497F-98D9-330E0F0225E1 @default.
- Q91064317 P2860 Q91064317-1298CF93-5162-47A9-8405-857806FEEF56 @default.
- Q91064317 P2860 Q91064317-29E7C2EA-1436-427D-B9AA-2BF0BD589D7B @default.
- Q91064317 P2860 Q91064317-2FD0EA68-4BD5-4086-A965-95CA2DCF8A6C @default.
- Q91064317 P2860 Q91064317-36510939-759A-481F-BB6C-267F960AFC70 @default.
- Q91064317 P2860 Q91064317-39516522-335F-4A9F-A83E-22FC0B45D51D @default.
- Q91064317 P2860 Q91064317-4004FC05-59D0-49A4-85AE-F7D950F88FE4 @default.
- Q91064317 P2860 Q91064317-515780E0-FD70-40C9-8B4C-C826CE19F2D5 @default.
- Q91064317 P2860 Q91064317-7DAF8144-672D-4A29-B280-7E80A20432CA @default.
- Q91064317 P2860 Q91064317-876E5F99-316A-45B2-A634-E026C1755D19 @default.
- Q91064317 P2860 Q91064317-8D493894-8E05-4BB5-BFF2-664A1013020F @default.
- Q91064317 P2860 Q91064317-96C20B4E-27DD-4E76-BB99-7905098AE41C @default.
- Q91064317 P2860 Q91064317-97214E5D-855D-4640-B10D-494BC9C8C5A7 @default.
- Q91064317 P2860 Q91064317-A86B2309-75A4-40CD-8E52-7278862FB871 @default.
- Q91064317 P2860 Q91064317-B57F594C-E581-4C62-B1D9-04818910C968 @default.
- Q91064317 P2860 Q91064317-C8B66CC7-C2A7-49A3-8E79-88BCF2A6FE5A @default.
- Q91064317 P2860 Q91064317-C9A23977-5EAB-44F6-B6C9-F89B8ED73AEE @default.
- Q91064317 P2860 Q91064317-E29FBD3F-2F9F-4EA7-8EAE-B3ED07A8F86F @default.
- Q91064317 P2860 Q91064317-E80316BE-8C52-4ADC-8DE1-52DC100732E2 @default.
- Q91064317 P2860 Q91064317-F79CA623-207E-405D-A13D-5456E6E71FE8 @default.
- Q91064317 P2860 Q91064317-FE408D6E-4605-482A-8D55-CE274EB1F186 @default.
- Q91064317 P31 Q91064317-71C573A8-D965-439A-BBFC-204FF0962AC1 @default.
- Q91064317 P356 Q91064317-39D4E454-CBD9-4316-BF13-8CC6340359EA @default.
- Q91064317 P577 Q91064317-29875365-64E4-411B-93BE-16422D7CADDE @default.
- Q91064317 P698 Q91064317-52E6B4F5-7530-430D-B32F-602F5CE762FC @default.
- Q91064317 P921 Q91064317-6E2AD86A-1DB3-4210-9799-0325200D8F07 @default.
- Q91064317 P356 CPT.1712 @default.
- Q91064317 P698 31677154 @default.
- Q91064317 P1433 Q1101529 @default.
- Q91064317 P1476 "Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab" @default.
- Q91064317 P2093 "Alexander G L Bodelier" @default.
- Q91064317 P2093 "Andrea E van der Meulen-de Jong" @default.
- Q91064317 P2093 "Annemarie C de Vries" @default.
- Q91064317 P2093 "Bas Oldenburg" @default.
- Q91064317 P2093 "C Janneke van der Woude" @default.
- Q91064317 P2093 "Dirk J de Jong" @default.
- Q91064317 P2093 "Frank Hoentjen" @default.
- Q91064317 P2093 "Gerard Dijkstra" @default.
- Q91064317 P2093 "Jeoffrey J L Haans" @default.
- Q91064317 P2093 "Jeroen M Jansen" @default.
- Q91064317 P2093 "Marie J Pierik" @default.
- Q91064317 P2093 "Mark Löwenberg" @default.
- Q91064317 P2093 "Nanne K de Boer" @default.
- Q91064317 P2093 "Nidhi Srivastava" @default.
- Q91064317 P2093 "Rachel L West" @default.
- Q91064317 P2093 "Vince B C Biemans" @default.
- Q91064317 P2860 Q33670059 @default.
- Q91064317 P2860 Q34365566 @default.
- Q91064317 P2860 Q34365574 @default.
- Q91064317 P2860 Q37848880 @default.
- Q91064317 P2860 Q38865053 @default.
- Q91064317 P2860 Q40503639 @default.
- Q91064317 P2860 Q40703329 @default.
- Q91064317 P2860 Q47312300 @default.
- Q91064317 P2860 Q48102896 @default.
- Q91064317 P2860 Q48308809 @default.
- Q91064317 P2860 Q48316242 @default.
- Q91064317 P2860 Q50764332 @default.
- Q91064317 P2860 Q53660410 @default.
- Q91064317 P2860 Q57051384 @default.
- Q91064317 P2860 Q64137296 @default.
- Q91064317 P2860 Q83463037 @default.
- Q91064317 P2860 Q84169795 @default.
- Q91064317 P2860 Q88990393 @default.
- Q91064317 P2860 Q89267486 @default.
- Q91064317 P2860 Q92530542 @default.
- Q91064317 P2860 Q92895315 @default.
- Q91064317 P31 Q13442814 @default.
- Q91064317 P356 "10.1002/CPT.1712" @default.
- Q91064317 P577 "2019-11-02T00:00:00Z" @default.